alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
MECHANICAL SYSTEMS & SERVICES, INC. v. CAROLINA AIR SOLUTIONS, L.L.C.

No. COA04-473

Court of Appeals of North Carolina

Filed January 18, 2005

Certification Date February 7, 2005

Case reported without published opinion. Dismissed.
# Official Journal C 66A/23 F

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 66A |
| | |
| English edition | Information and Notices | Volume 6623 February 2023 |

ISSN 1977-091X

Official Journal

of the European Union

C 66A

English edition

Information and Notices

Volume 6623 February 2023

---

| Contents | page |
| --- | --- |
| | V   Announcements |
| | ADMINISTRATIVE PROCEDURES |
| | Council |
| 2023/C 66 A/01 | Vacancy notice CONS/AD/185/23 | 1 |

Contents

page

V   Announcements

ADMINISTRATIVE PROCEDURES

Council

2023/C 66 A/01

Vacancy notice CONS/AD/185/23

1

---

| EN | |
| --- | --- |

EN
EXHIBIT 32.2





CERTIFICATIONS PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the Quarterly Report of National Beef Packing Company, LLC (the Company) on Form 10-Q for the period ended May 28, 2011 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Simon P. McGee, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section  1350, as adopted pursuant to Section  906 of the Sarbanes-Oxley Act of 2002, that:





(1)  The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and





(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.





By:/s/ Simon P. McGeeSimon P. McGeeChief Financial Officer


Date: July 8, 2011
KYLE & ASSOCIATES, INC. v. Thomas MAHAN, and Michael Auten.

No. 655PA03.

Supreme Court of North Carolina.

May 6, 2004.

Donald M. Brown, Jr., Charlotte, for Mahan and Auten.

Douglas P. Arthurs, Gastonia, for Kyle & Associates, Inc.

***ORDER***

Upon consideration of the petition filed on the 22nd day of December 2003 by Defendant in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Allowed by order of the Court in conference, this the 6th day of May 2004."

Defendant shall forthwith submit an appeal bond to this Court, as provided by Appellate Rule 17(b). The bond may be in cash or by a written undertaking with good and sufficient surety in the sum of $250.00.

Therefore the case is docketed as of the date of this order's certification. Briefs of the respective parties shall be submitted to this Court within the times allowed and in the manner provided by Appellate Rule 15(g)(2).
# Fourth Court of Appeals

**San Antonio, Texas**

May 24, 2019

No. 04

- 19

- 00322

- CR

Sean Anthony JONES

, Appellant

v.

The STATE of Texas, Appellee

From the County Court at Law No. 6, Bexar County, Texas

Trial Court No. 611752 Honorable Wayne A. Christian, Judge Presiding



### ORDER

Pursuant to a plea

- bargain agreement, appellant pleaded nolo contendere to the offense of resisting arrest

. The trial court assessed punishment at thirty

- nine days in jail with a fine of
$350.00 and court costs of $422.00 . On April 17 , 2019 , the trial court signed a certification of defendant’s right to appeal stating that this “is a plea

- bargain case, and the defendant has NO right of appeal.” See T EX

. R. A PP

. P. 25.2(a)(2).

“In a plea bargain case ... a defendant may appeal only: (A) those matters that were raised by written motion filed and ruled on before trial, or (B) after getting the trial court’s permission to appeal.” Id. 25.2(a)(2). The clerk’s record, which contains a written plea bargain, establishes the pu nishment assessed by the court does not exceed the punishment recommended by the prosecutor and agreed to by the defendant. See id. The clerk’s record does not include a written motion filed and ruled upon before trial; nor does it indicate that the tria l court gave its permission to appeal. See id. The trial court’s certification, therefore, appears to accurately reflect that this is a plea

- bargain case and that appellant does not have a right to appeal. We must dismiss an appeal “if a certification t hat shows the defendant has the right of appeal has not been made part of the record.” Id. 25.2(d).

This appeal will be dismissed pursuant to Texas Rule of Appellate Procedure 25.2(d), unless an amended trial court certification showing that appellant has the right to appeal is made part of the appellate record by June 24, 2019

. See T EX

. R. A PP

. P. 25.2(d), 37.1; Daniels v.

State , 110 S.W.3d 174 (Tex. App.

— San Antonio 2003, order).We ORDER all appellate deadli nes be suspended until further order of the court.

_________________________________ I rene Rios , Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

court on this 24th day of May, 2019

.

___________________________________ KEITH E. HOTTLE

, Clerk of Court
**Exhibit 32.2**

PHARMACOPEIA, INC.

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF2002

In connection with the Quarterly Report of Pharmacopeia, Inc. (the “Company”)on Form 10-Q for the period ended June 30, 2007, as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), I, BrianM. Posner, Executive Vice President and Chief Financial Officer (PrincipalFinancial Officer and Chief Accounting Officer) of the Company, hereby certifypursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934;and

(2)  The information contained in the Report fairly presents, inall material respects, the financial condition and results of operations of theCompany.
| By:    | /s/ Brian M. Posner                                         |   |   |
|--------|-------------------------------------------------------------|--------|--------|
|   | Brian M. Posner                                             |   |
|   | Executive Vice President,                                   |   |
|   | Chief Financial Officer and Treasurer                       |   |
|   | (Principal Financial Officer and Chief Accounting  Officer) |   |
|   | August 2, 2007                                              |   |

 

----
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Diversity and Health Disparities RFAs review.                    

*Date:*                         July 15, 2022.                    

*Time:*                         8:30 a.m. to 4:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Songtao Liu, MD, Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Suite 920, MSC 5469, Bethesda, MD 20817, (301) 827-3025,                         *songato.liu@nih.gov*.                    

(Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, HHS)

Dated: June 17, 2022.

Victoria E. Townsend,

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2022-13479 Filed 6-23-22; 8:45 am]

BILLING CODE 4140-01-P
Bobby Joe FLOYD, Petitioner, v. UNITED STATES.

No. 19-7947.

Supreme Court of the United States.

April 20, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Ninth Circuit denied.
STATE v. Wade Larry COLE.

No. 324A94-3.

Supreme Court of North Carolina.

August 12, 2004.

Marilyn G. Ozer, Chapel Hill, for Cole.

A. Danielle Marquis, Assistant Attorney General, Frank R. Parrish, District Attorney, for State.

The following order has been entered on the motion filed on the 16th day of June 2004 by Defendant to Defer Consideration of Petition for Writ of Certiorari (pending decision in State v Poindexter):

> "Motion Denied by order of the Court in conference this the 12th day of August 2004."
'FEB 27 2915 ^?^ ^ ^^^/ £> Fl cy^
EXHIBIT 12(a)

                       CHASE PREFERRED CAPITAL CORPORATION
                Computation of ratio of earnings to fixed charges


                                       For the Year             For the Year
(in thousands, except ratio):         Ended 12/31/98           Ended 12/31/97
--------------------------------------------------------------------------------

Net income                            $     76,559             $    79,779
                                      ------------             -----------

Fixed charges:
      Advisory fees                            250                    250
                                      ------------            -----------

Total fixed charges                            250                    250
                                      ------------            -----------

Earnings before fixed charges         $     76,809            $    80,029
                                      ============            ===========

Fixed charges, as above               $        250            $       250
                                      ============            ===========

Ratio of earnings to fixed charges          307.24                 320.12
                                      ============            ===========
United Technologies Corporation Nonemployee Director Stock Option Plan


  
 Exhibit 10.12

  
 UNITED TECHNOLOGIES CORPORATION 
 NONEMPLOYEE DIRECTOR STOCK OPTION PLAN 
  
 Amendment 5 
  
 Whereas, the United Technologies Corporation Nonemployee Director Stock Option Plan (the “Plan”) was adopted by the Corporation and approved by
shareowners April 23, 1996; and 
  
 Whereas, the New York Stock Exchange
has amended its listing standards relative to shareholder approval requirements of equity compensation arrangements to require, among other things, that the Plan have a ten-year term limit effective from the date of the most recent shareholder
approval; 
  
 Now therefore, the Plan is hereby amended as follows: 
  

	1.	Section 13 of the Plan is amended and restated as follows: 

  

	13.	Termination of Plan 

  
 The Plan shall continue in effect until such time as the Board acts to terminate the Plan, provided, however, that the Plan shall not continue beyond
April 22, 2006 unless extended by a majority vote of the Corporation’s shareowners. 
  

			
	UNITED TECHNOLOGIES CORPORATION
		
	 	 	 
	 	 	 William L. Bucknall, Jr.
 Sr. Vice President Human Resources
 and Organization


  

	
	Attest:
	
	  
	 Richard M. Kaplan

	
	 Date: January 28, 2004
H. R. 4918 

One Hundred Tenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Thursday, 

the third day of January, two thousand and eight 

An Act 

To name the Department of Veterans Affairs medical center in Miami, Florida, 

as the ‘‘Bruce W. Carter Department of Veterans Affairs Medical Center’’. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. NAME OF DEPARTMENT OF VETERANS AFFAIRS MEDICAL 

CENTER, MIAMI, FLORIDA. 

The Department of Veterans Affairs medical center in Miami, 

Florida, shall after the date of the enactment of this Act be known 

and designated as the ‘‘Bruce W. Carter Department of Veterans 

Affairs Medical Center’’. Any reference to such medical center in 

any law, regulation, map, document, record, or other paper of the 

United States shall be considered to be a reference to the Bruce 

W. Carter Department of Veterans Affairs Medical Center. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
<PAGE>

                                                                    Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Millennium Chemicals Inc. (the
"Company") on Form 10-K for the year ending December 31, 2003 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Robert
E. Lee, President and Chief Executive Officer of the Company, certify, pursuant
to 18 U.S.C. 'SS'1350, as adopted pursuant to 'SS'906 of the Sarbanes-Oxley
Act of 2002, that:

     (1) The Report fully complies with the requirements of Section 13 or 15(d)
of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

Date: March 12, 2004


                                                    /s/ ROBERT E. LEE
                                         ---------------------------------------
                                                      Robert E. Lee
                                         President and Chief Executive Officer

This certification, which is required by Section 906 of the Sarbanes-Oxley Act
of 2002, is "furnished" to the Securities and Exchange Commission in accordance
with Item 601(b)(32)(ii) of Regulation S-K, 17 CFR 229.601(b)(32)(ii).
Edward Bernard DAY v. STATE of North Carolina.

No. 346P04.

Supreme Court of North Carolina.

December 2, 2004.

Edward B. Day, Pro Se.

Daniel P. O'Brien, Raleigh, R. Stuart Albright, District Attorney, for State.

***ORDER***

Upon consideration of the petition filed by Plaintiff on the 7th day of July 2004 in this matter for a writ of certiorari to review the order of the North Carolina Court of Appeals, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

> "Dismissed by order of the Court in conference, this the 2nd day of December 2004."
**EXHIBIT 32.1**

CERTIFICATIONPURSUANT TO

18U.S.C. SECTION 1350,

ASADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350 (as adopted pursuant to Section 906of the Sarbanes-Oxley Act of 2002), I, the undersigned Chief Executive Officerof GrayMark Productions, Inc. (the “Company”), hereby certify that, to the bestof my knowledge, the Quarterly Report on Form 10-QSB of the Company for thethree months ended June 30, 2007 (the “Quarterly Report”) fully complies withthe requirements of section 13(a) or 15(d) of the Securities Exchange Act of1934 and that information contained in the Quarterly Report fairly presents, inall material respects, the financial condition and results of operations of theCompany.
| Date:  August  8, 2007 | /s/ JOHN  SIMONELLI      |
|----------------------------------|--------------------------|
|                             | Chief Executive  Officer |

 

----
Independent Auditors' Report


To the Shareholders and Board of Directors of
High Income Opportunity Fund Inc.:

In planning and performing our audit of the financial statements
of the High Income Opportunity Fund Inc. (the Fund) for the
year ended September 30, 2001, we considered its internal
control, including control activities for safeguarding
securities, in order to determine our auditing procedures for the
purpose of expressing our opinion on the financial statements and
to comply with the requirements of Form N-SAR, not to provide
assurance on the internal control.

The management of the Fund is responsible for establishing and
maintaining internal control.  In fulfilling this responsibility,
estimates and judgments by management are required to assess the
expected benefits and related costs of controls.  Generally,
controls that are relevant to an audit pertain to the entity's
objective of preparing financial statements for external purposes
that are fairly presented in conformity with generally accepted
accounting principles. Those controls include the safeguarding of
assets against unauthorized acquisition, use, or disposition.

Because of inherent limitations in internal control, error or
fraud may occur and not be detected.  Also, projection of any
evaluation of internal control to future periods is subject to
the risk that it may become inadequate because of changes in
conditions or that the effectiveness of the design and operation
may deteriorate.

Our consideration of the internal control would not necessarily
disclose all matters in the internal control that might be
material weaknesses under standards established by the American
Institute of Certified Public Accountants.  A material weakness
is a condition in which the design or operation of one or more of
the internal control components does not reduce to a relatively
low level the risk that misstatements caused by error or fraud in
amounts that would be material in relation to the financial
statements being audited may occur and not be detected within a
timely period by employees in the normal course of performing
their assigned functions.  However, we noted no matters involving
the internal control and its operation, including controls for
safeguarding securities that we consider to be material
weaknesses as defined above.

This report is intended solely for the information and use of
management, the Board of Directors of the Fund, and the
Securities and Exchange Commission and is not intended to be and
should not be used by anyone other than these specified parties.



KPMG LLP

New York, New York
November 13, 2001
EXHIBIT 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Report on Form 10-QSB (the "Report") of Del Mar Income
Partners, Ltd. (the "Company") for the quarter ended March 31, 2007, each of the
undersigned, Stephen D. Replin, the Chief Executive Officer of the Company, and
Wanda E. Wages, the Secretary and Treasurer of the Company, each hereby
certifies that, to the best of her/his knowledge:

     1. The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934, as amended; and


     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Dated:  May 10, 2007


/s/ Stephen D. Replin                             /s/ Wanda E. Wages
---------------------                             -----------------
 Stephen D. Replin                                Wanda E. Wages
 Chief Executive Officer                          Secretary and Treasurer
(Principal Executive Officer)                    (Principal Financial Officer)
KING v. SPEEDWAY MOTORSPORTS.

No. 302P04.

Supreme Court of North Carolina.

June 24, 2004.

David N. Allen, Patrick J. Fogarty, Charlotte, for Speedway Motorsports.

James T. Williams, Jr., Reid L. Phillips, Greensboro, for Tindall Corporation.

The following order has been entered on the motion filed on the 17th day of June 2004 by Plaintiff (Patricia C. King) for Stay of Trial Court Proceedings:

> "Motion Allowed by order of the Court in conference this the 24th day of June 2004."

Justice MARTIN recused.
EXHIBIT 13 (b)



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



I, Erik Danielsen, CFO of Nymox Pharmaceutical Corporation, do hereby certify that, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the information contained in the Annual Report for the period ended December 31, 2017 of Nymox Pharmaceutical Corporation and filed with the Securities and Exchange Commission, fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Nymox Pharmaceutical Corporation





|Date: May 11, 2018 |                                 
|------------------ | --------------------------------
|                   |                                 
|By:                | /s/ Erik Danielsen              
|                   | Erik Danielsen                  
|                   | Chief Financial Officer         
|                   | Nymox Pharmaceutical Corporation
Ronald F. LEE, v. UNITED STATES.

No. 19-5790 (R46-010)

Supreme Court of the United States.

February 18, 2020

The petition for writ of certiorari was dismissed today pursuant to Rule 46 of the Rules of this Court.
IN THE COMMONWEALTH COURT OF PENNSYLVANIA

Deree J. Norman, :

Petitioner :

:

v. : No. 690 C.D. 2020

:

Pennsylvania Public Utility :

Commission, :

Respondent :

PER CURIAM O R D E R

NOW, April 20, 2021

, upon consideration of P etitioner’s

application for re consideration and R espondent’s answer in response thereto,

the application is denied.